iCAD announced its “ProFound Insights, ProFound Impact” webinar series will feature Dr. Laura Dean, a renowned breast radiologist at the Cleveland Clinic. Titled “How Cleveland Clinic is Finding the Breast Cancers Radiologists Fear the Most,” the live event will take place on Thursday, July 20 at 10 am ET. The event will be moderated by iCAD‘s President and CEO, Dana Brown. During the event, Dr. Dean will discuss how she leverages iCAD’s technology to detect breast cancers, including small, subtle tumors – the types of cancers radiologists fear the most. She will also present a live clinical case review showcasing how ProFound AI can enhance cancer detection in a clinical setting.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ICAD:
- iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic
- iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting
- iCAD showcases its ProFound AI Suite at AHRA 2023
- iCAD Reports Financial Results for First Quarter Ended March 31, 2023